Mirum Pharmaceuticals Inc. (MIRM) NASDAQ
$30.80 0.42 (1.38%)
Market Cap: $1.18B
As of 09/27/23 04:00 PM EDT. Market closed.
Mirum Pharmaceuticals Inc. (MIRM)
NASDAQ
$30.80
0.42 (1.38%)
Market Cap: $1.18B
As of 09/27/23 04:00 PM EDT. Market closed.
mirum pharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. its lead product candidate is maralixibat, an investigational oral drug that is in phase 3 clinical trial for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of ... read more
mirum pharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. its lead product candidate is maralixibat, an investigational oral drug that is in phase 3 clinical trial for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of alagille syndrome and biliary atresia disease. the company is also develops volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. mirum pharmaceuticals, inc. was founded in 2018 and is headquartered in foster city, california. read less
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
198
Address
.
PRICE CHART FOR MIRUM PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$24.95
Previous Close
$30.38
Days Range
$30.35 - $31.03
52 week range
$17.32 - $33.39
Volume
288,728
Avg. Volume (30 days)
753,802
Market Cap
$1.18B
Dividend Yield
-
P/E
(6.69)
Shares Outstanding
38,297,975
Open
$24.95
Previous Close
$30.38
Days Range
$30.35 - $31.03
52 week range
$17.32 - $33.39
Volume
288,728
Avg. Volume (30 days)
753,802
Market Cap
$1.18B
Dividend Yield
-
P/E
(6.69)
Shares Outstanding
38,297,975
FINANCIAL STATEMENTS FOR MIRUM PHARMACEUTICALS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR MIRUM PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Heron Patrick J | Director | Sep 13, 2023 | Buy | $31.02 | 2,625 | 81,425 | 159,053 | Sep 15, 2023, 04:56 PM |
| GREY MICHAEL G | Director | Sep 14, 2023 | Option Exercise | $2.94 | 14,216 | 41,738 | 14,216 | Sep 14, 2023, 07:33 PM |
| GREY MICHAEL G | Director | Sep 13, 2023 | Option Exercise | $2.94 | 392 | 1,151 | 392 | Sep 14, 2023, 07:33 PM |
| GREY MICHAEL G | Director | Sep 14, 2023 | Sale | $32.00 | 14,216 | 454,912 | 0 | Sep 14, 2023, 07:33 PM |
| GREY MICHAEL G | Director | Sep 13, 2023 | Sale | $32.00 | 392 | 12,544 | 0 | Sep 14, 2023, 07:33 PM |
| BJERKHOLT ERIC | Chief Financial Officer | Sep 11, 2023 | Buy | $29.65 | 10,000 | 296,492 | 10,000 | Sep 12, 2023, 06:23 PM |
| Heron Patrick J | Director | Aug 31, 2023 | Buy | $26.25 | 147,991 | 3,884,764 | 147,991 | Sep 05, 2023, 12:51 PM |
| Howe Jolanda | SVP, Global Controller | Aug 25, 2023 | Sale | $26.23 | 3,459 | 90,743 | 0 | Aug 28, 2023, 04:30 PM |
| Radovich Peter | Chief Operating Officer | Jul 03, 2023 | Sale | $25.65 | 1,425 | 36,546 | 37,675 | Jul 05, 2023, 07:47 PM |
| Longpre Lara | Chief Development Officer | Jul 03, 2023 | Sale | $25.65 | 1,004 | 25,749 | 105,839 | Jul 05, 2023, 07:37 PM |
| Vig Pamela | Head of Research & Development | Jul 03, 2023 | Sale | $25.65 | 1,425 | 36,546 | 30,786 | Jul 05, 2023, 07:35 PM |
| Howe Jolanda | SVP, Global Controller | Jul 03, 2023 | Sale | $25.65 | 915 | 23,467 | 3,459 | Jul 05, 2023, 07:33 PM |
| Peetz Christopher | President and CEO | Jul 03, 2023 | Sale | $25.65 | 5,498 | 141,005 | 115,334 | Jul 05, 2023, 07:30 PM |
| GREY MICHAEL G | Director | Jun 08, 2023 | Option Exercise | $2.94 | 14,608 | 42,889 | 14,608 | Jun 09, 2023, 04:20 PM |
| GREY MICHAEL G | Director | Jun 08, 2023 | Sale | $29.00 | 14,608 | 423,632 | 0 | Jun 09, 2023, 04:20 PM |
| Vig Pamela | Head of Research & Development | May 10, 2023 | Option Exercise | $16.92 | 684 | 11,576 | 32,211 | May 19, 2023, 04:05 PM |
| GREY MICHAEL G | Director | May 03, 2023 | Option Exercise | $2.94 | 14,608 | 42,889 | 14,608 | May 04, 2023, 09:58 PM |
| GREY MICHAEL G | Director | May 03, 2023 | Sale | $28.00 | 14,608 | 409,024 | 0 | May 04, 2023, 09:58 PM |
| O'Donnell Niall | Director | Nov 14, 2022 | Sale | $19.60 | 32,109 | 629,423 | 1,714,888 | Nov 15, 2022, 08:02 PM |
| O'Donnell Niall | Director | Nov 11, 2022 | Sale | $19.99 | 174,121 | 3,481,410 | 1,746,997 | Nov 15, 2022, 08:02 PM |
| O'Donnell Niall | Director | Nov 15, 2022 | Sale | $19.69 | 93,770 | 1,846,022 | 1,621,118 | Nov 15, 2022, 08:02 PM |
| Clements Ian | Chief Financial Officer | Nov 10, 2022 | Option Exercise | $17.05 | 325 | 5,542 | 30,011 | Nov 14, 2022, 09:46 PM |
| Peetz Christopher | President and CEO | Nov 10, 2022 | Option Exercise | $17.05 | 49 | 835 | 69,576 | Nov 14, 2022, 09:45 PM |
| Vig Pamela | Head of Research & Development | Nov 10, 2022 | Option Exercise | $17.05 | 660 | 11,254 | 21,902 | Nov 14, 2022, 09:43 PM |
| Radovich Peter | Chief Operating Officer | Nov 10, 2022 | Option Exercise | $17.05 | 292 | 4,979 | 23,692 | Nov 14, 2022, 09:41 PM |
| Longpre Lara | Chief Development Officer | Nov 10, 2022 | Option Exercise | $17.05 | 82 | 1,398 | 96,534 | Nov 14, 2022, 09:40 PM |
| Flynn James E | 10% Owner | Jun 06, 2022 | Sale | $25.01 | 18,266 | 456,795 | 1,546,588 | Jun 08, 2022, 07:25 PM |
| Flynn James E | 10% Owner | Jun 06, 2022 | Sale | $25.01 | 20,212 | 505,460 | 1,711,324 | Jun 08, 2022, 07:25 PM |
| Radovich Peter | Chief Operating Officer | May 10, 2022 | Option Exercise | $13.57 | 1,169 | 15,859 | 23,400 | May 12, 2022, 09:24 PM |
| Longpre Lara | Chief Development Officer | May 10, 2022 | Option Exercise | $13.57 | 1,454 | 19,725 | 96,452 | May 12, 2022, 09:23 PM |
| Vig Pamela | Head of Research & Development | May 10, 2022 | Option Exercise | $13.57 | 807 | 10,948 | 21,242 | May 12, 2022, 09:21 PM |
| Peetz Christopher | President and CEO | May 10, 2022 | Option Exercise | $13.57 | 1,500 | 20,349 | 69,527 | May 12, 2022, 09:17 PM |
| Clements Ian | Chief Financial Officer | May 10, 2022 | Option Exercise | $13.57 | 1,125 | 15,262 | 29,686 | May 12, 2022, 09:14 PM |
| Clements Ian | Chief Financial Officer | Nov 26, 2021 | Buy | $13.90 | 750 | 10,425 | 18,561 | Nov 29, 2021, 09:49 PM |
| Clements Ian | Chief Financial Officer | Nov 24, 2021 | Buy | $14.40 | 700 | 10,080 | 17,811 | Nov 29, 2021, 09:49 PM |
| Peetz Christopher | President and CEO | Nov 24, 2021 | Buy | $14.40 | 7,000 | 100,800 | 28,027 | Nov 29, 2021, 09:47 PM |
| Vig Pamela | Chief Scientific Officer | Nov 10, 2021 | Option Exercise | $13.52 | 768 | 10,380 | 10,435 | Nov 15, 2021, 04:26 PM |
| Tucker Edwin Jonathan | Chief Medical Officer | Nov 10, 2021 | Option Exercise | $13.52 | 70 | 946 | 45,838 | Nov 15, 2021, 04:23 PM |
| Radovich Peter | Chief Operating Officer | Nov 10, 2021 | Option Exercise | $13.52 | 958 | 12,947 | 12,231 | Nov 15, 2021, 04:21 PM |
| Longpre Lara | Chief Development Officer | Nov 10, 2021 | Option Exercise | $13.52 | 753 | 10,177 | 84,998 | Nov 15, 2021, 04:19 PM |
| Clements Ian | Chief Financial Officer | Nov 10, 2021 | Option Exercise | $13.52 | 458 | 6,190 | 17,111 | Nov 15, 2021, 04:16 PM |
| Peetz Christopher | President and CEO | Oct 01, 2021 | Sale | $19.26 | 3,672 | 70,708 | 21,027 | Oct 01, 2021, 08:00 PM |
| Vig Pamela | Chief Scientific Officer | Oct 01, 2021 | Sale | $19.26 | 1,364 | 26,265 | 9,667 | Oct 01, 2021, 08:00 PM |
| Clements Ian | Chief Financial Officer | Oct 01, 2021 | Sale | $19.26 | 1,574 | 30,309 | 16,653 | Oct 01, 2021, 08:00 PM |
| Longpre Lara | Chief Development Officer | Oct 01, 2021 | Sale | $19.26 | 961 | 18,505 | 84,245 | Oct 01, 2021, 08:00 PM |
| Radovich Peter | Chief Operating Officer | Oct 01, 2021 | Sale | $19.26 | 1,364 | 26,265 | 11,273 | Oct 01, 2021, 08:00 PM |
| Tucker Edwin Jonathan | Chief Medical Officer | Oct 01, 2021 | Sale | $19.26 | 1,364 | 26,265 | 45,768 | Oct 01, 2021, 08:00 PM |
| Flynn James E | 10% Owner | Jul 09, 2021 | Sale | $15.81 | 99,325 | 1,570,328 | 0 | Jul 13, 2021, 12:06 PM |
| Flynn James E | 10% Owner | Jul 07, 2021 | Sale | $15.87 | 6,837 | 108,496 | 99,325 | Jul 07, 2021, 06:48 PM |
| Flynn James E | 10% Owner | Jul 06, 2021 | Sale | $16.19 | 49,239 | 797,426 | 106,162 | Jul 07, 2021, 06:48 PM |
| Flynn James E | 10% Owner | Jul 02, 2021 | Sale | $17.01 | 10,599 | 180,300 | 155,401 | Jul 07, 2021, 06:48 PM |
| Tucker Edwin Jonathan | Chief Medical Officer | May 10, 2021 | Option Exercise | $14.62 | 1,483 | 21,681 | 39,007 | May 12, 2021, 05:46 PM |
| Radovich Peter | Chief Operating Officer | May 10, 2021 | Option Exercise | $14.62 | 1,006 | 14,708 | 4,512 | May 12, 2021, 05:45 PM |
| Peetz Christopher | President and CEO | May 10, 2021 | Option Exercise | $14.62 | 1,453 | 21,243 | 2,824 | May 12, 2021, 05:41 PM |
| Longpre Lara | Chief Development Officer | May 10, 2021 | Option Exercise | $14.62 | 1,259 | 18,407 | 77,081 | May 12, 2021, 05:38 PM |
| Clements Ian | Chief Financial Officer | Dec 23, 2020 | Buy | $18.65 | 1,592 | 29,691 | 7,871 | Mar 08, 2021, 07:42 PM |
| Tucker Edwin Jonathan | Chief Medical Officer | Mar 05, 2021 | Option Exercise | $7.70 | 1,082 | 8,331 | 37,524 | Mar 08, 2021, 06:40 PM |
| Tucker Edwin Jonathan | Chief Medical Officer | Dec 28, 2020 | Option Exercise | $7.70 | 4,167 | 32,086 | 36,442 | Dec 29, 2020, 04:24 PM |
| Clements Ian | Chief Financial Officer | Dec 23, 2020 | Buy | $18.61 | 2,470 | 45,975 | 7,841 | Dec 28, 2020, 04:12 PM |
| Peetz Christopher | President and CEO | Dec 23, 2020 | Buy | $18.70 | 5,000 | 93,480 | 201,570 | Dec 28, 2020, 04:06 PM |
| Vig Pamela | Chief Scientific Officer | Nov 10, 2020 | Option Exercise | $15.27 | 595 | 9,083 | 2,207 | Nov 12, 2020, 05:20 PM |
| Radovich Peter | Chief Operating Officer | Nov 10, 2020 | Option Exercise | $15.27 | 861 | 13,144 | 3,506 | Nov 12, 2020, 05:16 PM |
| Longpre Lara | Chief Development Officer | Nov 10, 2020 | Option Exercise | $15.27 | 822 | 12,549 | 75,822 | Nov 12, 2020, 05:14 PM |
| Tucker Edwin Jonathan | Chief Medical Officer | Nov 10, 2020 | Option Exercise | $15.27 | 1,275 | 19,464 | 32,275 | Nov 12, 2020, 05:12 PM |
| Clements Ian | Chief Financial Officer | Nov 10, 2020 | Option Exercise | $15.27 | 1,371 | 20,930 | 5,371 | Nov 12, 2020, 05:06 PM |
| Peetz Christopher | President and CEO | Nov 10, 2020 | Option Exercise | $15.27 | 1,371 | 20,930 | 1,371 | Nov 12, 2020, 05:03 PM |
| Tucker Edwin Jonathan | Chief Medical Officer | Oct 30, 2020 | Option Exercise | $7.70 | 25,000 | 192,500 | 31,000 | Nov 03, 2020, 05:09 PM |
| Tucker Edwin Jonathan | Chief Medical Officer | Mar 20, 2020 | Buy | $11.90 | 2,500 | 29,740 | 6,000 | Mar 23, 2020, 04:47 PM |
| Tucker Edwin Jonathan | Chief Medical Officer | Mar 19, 2020 | Buy | $9.91 | 2,000 | 19,818 | 3,500 | Mar 23, 2020, 04:47 PM |
| Fischer Laurent | Director | Sep 17, 2019 | Buy | $9.37 | 1,648 | 15,435 | 6,750 | Sep 18, 2019, 05:23 PM |
| Fischer Laurent | Director | Sep 16, 2019 | Buy | $9.47 | 452 | 4,280 | 5,102 | Sep 18, 2019, 05:23 PM |
| Brege Laura | Director | Sep 10, 2019 | Buy | $11.22 | 10,000 | 112,200 | 10,000 | Sep 12, 2019, 04:21 PM |
| Clements Ian | SVP Finance & Communications | Sep 06, 2019 | Buy | $11.51 | 4,000 | 46,039 | 4,000 | Sep 10, 2019, 07:19 PM |
| Vig Pamela | Chief Scientific Officer | Sep 06, 2019 | Buy | $10.97 | 1,612 | 17,682 | 1,612 | Sep 10, 2019, 07:17 PM |
| Peetz Christopher | President and CEO | Sep 09, 2019 | Buy | $11.14 | 4,320 | 48,132 | 196,570 | Sep 10, 2019, 07:11 PM |
| Peetz Christopher | President and CEO | Sep 06, 2019 | Buy | $10.91 | 4,750 | 51,806 | 192,250 | Sep 10, 2019, 07:11 PM |
| Fischer Laurent | Director | Sep 09, 2019 | Buy | $10.66 | 1,970 | 20,992 | 3,690 | Sep 10, 2019, 07:10 PM |
| Fischer Laurent | Director | Sep 06, 2019 | Buy | $10.71 | 1,720 | 18,429 | 1,720 | Sep 10, 2019, 07:10 PM |
| Fischer Laurent | Director | Sep 10, 2019 | Buy | $10.29 | 960 | 9,881 | 4,650 | Sep 10, 2019, 07:10 PM |
| Walker Paul Edward | 10% Owner | Jul 22, 2019 | Buy | $15.00 | 450,000 | 6,750,000 | 4,186,243 | Jul 24, 2019, 04:57 PM |
| Sonsini Peter W. | 10% Owner | Jul 22, 2019 | Buy | $15.00 | 450,000 | 6,750,000 | 4,186,243 | Jul 24, 2019, 04:56 PM |
| SANDELL SCOTT D | 10% Owner | Jul 22, 2019 | Buy | $15.00 | 450,000 | 6,750,000 | 4,186,243 | Jul 24, 2019, 04:56 PM |
| MOTT DAVID M | 10% Owner | Jul 22, 2019 | Buy | $15.00 | 450,000 | 6,750,000 | 4,186,243 | Jul 24, 2019, 04:55 PM |
| MAKOWER JOSHUA | 10% Owner | Jul 22, 2019 | Buy | $15.00 | 450,000 | 6,750,000 | 4,186,243 | Jul 24, 2019, 04:55 PM |
| Makhzoumi Mohamad | 10% Owner | Jul 22, 2019 | Buy | $15.00 | 450,000 | 6,750,000 | 4,186,243 | Jul 24, 2019, 04:54 PM |
| Florence Anthony A. Jr. | 10% Owner | Jul 22, 2019 | Buy | $15.00 | 450,000 | 6,750,000 | 4,186,243 | Jul 24, 2019, 04:54 PM |
| Chang Carmen | 10% Owner | Jul 22, 2019 | Buy | $15.00 | 450,000 | 6,750,000 | 4,186,243 | Jul 24, 2019, 04:53 PM |
| Behbahani Ali | 10% Owner | Jul 22, 2019 | Buy | $15.00 | 450,000 | 6,750,000 | 4,186,243 | Jul 24, 2019, 04:53 PM |
| BASKETT FOREST | 10% Owner | Jul 22, 2019 | Buy | $15.00 | 450,000 | 6,750,000 | 4,186,243 | Jul 24, 2019, 04:52 PM |
| BARRIS PETER J | 10% Owner | Jul 22, 2019 | Buy | $15.00 | 450,000 | 6,750,000 | 4,186,243 | Jul 24, 2019, 04:52 PM |
| New Enterprise Associates 16, L.P. | 10% Owner | Jul 22, 2019 | Buy | $15.00 | 450,000 | 6,750,000 | 4,186,243 | Jul 24, 2019, 04:51 PM |
| Frazier Life Sciences IX, L.P. | 10% Owner | Jul 22, 2019 | Buy | $15.00 | 450,000 | 6,750,000 | 3,566,912 | Jul 24, 2019, 04:17 PM |
| O'Donnell Niall | Director | Jul 22, 2019 | Buy | $15.00 | 300,000 | 4,500,000 | 1,921,118 | Jul 24, 2019, 04:16 PM |
| Heron Patrick J | Director | Jul 22, 2019 | Buy | $15.00 | 450,000 | 6,750,000 | 3,566,912 | Jul 24, 2019, 04:12 PM |
| Flynn James E | 10% Owner | Jul 22, 2019 | Buy | $15.00 | 166,000 | 2,490,000 | 166,000 | Jul 24, 2019, 02:18 PM |
| Flynn James E | 10% Owner | Jul 22, 2019 | Buy | $15.00 | 166,000 | 2,490,000 | 1,724,456 | Jul 24, 2019, 02:18 PM |
| Novo Holdings A/S | 10% Owner | Jul 22, 2019 | Buy | $15.00 | 575,000 | 8,625,000 | 2,445,147 | Jul 23, 2019, 04:32 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Heron Patrick J | Director | 09/13/2023 | 81,425 |
| GREY MICHAEL G | Director | 09/14/2023 | 41,738 |
| GREY MICHAEL G | Director | 09/13/2023 | 1,151 |
| GREY MICHAEL G | Director | 09/14/2023 | 454,912 |
| GREY MICHAEL G | Director | 09/13/2023 | 12,544 |
| BJERKHOLT ERIC | Chief Financial Officer | 09/11/2023 | 296,492 |
| Heron Patrick J | Director | 08/31/2023 | 3,884,764 |
| Howe Jolanda | SVP, Global Controller | 08/25/2023 | 90,743 |
| Radovich Peter | Chief Operating Officer | 07/03/2023 | 36,546 |
| Longpre Lara | Chief Development Officer | 07/03/2023 | 25,749 |
| Vig Pamela | Head of Research & Development | 07/03/2023 | 36,546 |
| Howe Jolanda | SVP, Global Controller | 07/03/2023 | 23,467 |
| Peetz Christopher | President and CEO | 07/03/2023 | 141,005 |
| GREY MICHAEL G | Director | 06/08/2023 | 42,889 |
| GREY MICHAEL G | Director | 06/08/2023 | 423,632 |
| Vig Pamela | Head of Research & Development | 05/10/2023 | 11,576 |
| GREY MICHAEL G | Director | 05/03/2023 | 42,889 |
| GREY MICHAEL G | Director | 05/03/2023 | 409,024 |
| O'Donnell Niall | Director | 11/14/2022 | 629,423 |
| O'Donnell Niall | Director | 11/11/2022 | 3,481,410 |
| O'Donnell Niall | Director | 11/15/2022 | 1,846,022 |
| Clements Ian | Chief Financial Officer | 11/10/2022 | 5,542 |
| Peetz Christopher | President and CEO | 11/10/2022 | 835 |
| Vig Pamela | Head of Research & Development | 11/10/2022 | 11,254 |
| Radovich Peter | Chief Operating Officer | 11/10/2022 | 4,979 |
| Longpre Lara | Chief Development Officer | 11/10/2022 | 1,398 |
| Flynn James E | 10% Owner | 06/06/2022 | 456,795 |
| Flynn James E | 10% Owner | 06/06/2022 | 505,460 |
| Radovich Peter | Chief Operating Officer | 05/10/2022 | 15,859 |
| Longpre Lara | Chief Development Officer | 05/10/2022 | 19,725 |
| Vig Pamela | Head of Research & Development | 05/10/2022 | 10,948 |
| Peetz Christopher | President and CEO | 05/10/2022 | 20,349 |
| Clements Ian | Chief Financial Officer | 05/10/2022 | 15,262 |
| Clements Ian | Chief Financial Officer | 11/26/2021 | 10,425 |
| Clements Ian | Chief Financial Officer | 11/24/2021 | 10,080 |
| Peetz Christopher | President and CEO | 11/24/2021 | 100,800 |
| Vig Pamela | Chief Scientific Officer | 11/10/2021 | 10,380 |
| Tucker Edwin Jonathan | Chief Medical Officer | 11/10/2021 | 946 |
| Radovich Peter | Chief Operating Officer | 11/10/2021 | 12,947 |
| Longpre Lara | Chief Development Officer | 11/10/2021 | 10,177 |
| Clements Ian | Chief Financial Officer | 11/10/2021 | 6,190 |
| Peetz Christopher | President and CEO | 10/01/2021 | 70,708 |
| Vig Pamela | Chief Scientific Officer | 10/01/2021 | 26,265 |
| Clements Ian | Chief Financial Officer | 10/01/2021 | 30,309 |
| Longpre Lara | Chief Development Officer | 10/01/2021 | 18,505 |
| Radovich Peter | Chief Operating Officer | 10/01/2021 | 26,265 |
| Tucker Edwin Jonathan | Chief Medical Officer | 10/01/2021 | 26,265 |
| Flynn James E | 10% Owner | 07/09/2021 | 1,570,328 |
| Flynn James E | 10% Owner | 07/07/2021 | 108,496 |
| Flynn James E | 10% Owner | 07/06/2021 | 797,426 |
| Flynn James E | 10% Owner | 07/02/2021 | 180,300 |
| Tucker Edwin Jonathan | Chief Medical Officer | 05/10/2021 | 21,681 |
| Radovich Peter | Chief Operating Officer | 05/10/2021 | 14,708 |
| Peetz Christopher | President and CEO | 05/10/2021 | 21,243 |
| Longpre Lara | Chief Development Officer | 05/10/2021 | 18,407 |
| Clements Ian | Chief Financial Officer | 12/23/2020 | 29,691 |
| Tucker Edwin Jonathan | Chief Medical Officer | 03/05/2021 | 8,331 |
| Tucker Edwin Jonathan | Chief Medical Officer | 12/28/2020 | 32,086 |
| Clements Ian | Chief Financial Officer | 12/23/2020 | 45,975 |
| Peetz Christopher | President and CEO | 12/23/2020 | 93,480 |
| Vig Pamela | Chief Scientific Officer | 11/10/2020 | 9,083 |
| Radovich Peter | Chief Operating Officer | 11/10/2020 | 13,144 |
| Longpre Lara | Chief Development Officer | 11/10/2020 | 12,549 |
| Tucker Edwin Jonathan | Chief Medical Officer | 11/10/2020 | 19,464 |
| Clements Ian | Chief Financial Officer | 11/10/2020 | 20,930 |
| Peetz Christopher | President and CEO | 11/10/2020 | 20,930 |
| Tucker Edwin Jonathan | Chief Medical Officer | 10/30/2020 | 192,500 |
| Tucker Edwin Jonathan | Chief Medical Officer | 03/20/2020 | 29,740 |
| Tucker Edwin Jonathan | Chief Medical Officer | 03/19/2020 | 19,818 |
| Fischer Laurent | Director | 09/17/2019 | 15,435 |
| Fischer Laurent | Director | 09/16/2019 | 4,280 |
| Brege Laura | Director | 09/10/2019 | 112,200 |
| Clements Ian | SVP Finance & Communications | 09/06/2019 | 46,039 |
| Vig Pamela | Chief Scientific Officer | 09/06/2019 | 17,682 |
| Peetz Christopher | President and CEO | 09/09/2019 | 48,132 |
| Peetz Christopher | President and CEO | 09/06/2019 | 51,806 |
| Fischer Laurent | Director | 09/09/2019 | 20,992 |
| Fischer Laurent | Director | 09/06/2019 | 18,429 |
| Fischer Laurent | Director | 09/10/2019 | 9,881 |
| Walker Paul Edward | 10% Owner | 07/22/2019 | 6,750,000 |
| Sonsini Peter W. | 10% Owner | 07/22/2019 | 6,750,000 |
| SANDELL SCOTT D | 10% Owner | 07/22/2019 | 6,750,000 |
| MOTT DAVID M | 10% Owner | 07/22/2019 | 6,750,000 |
| MAKOWER JOSHUA | 10% Owner | 07/22/2019 | 6,750,000 |
| Makhzoumi Mohamad | 10% Owner | 07/22/2019 | 6,750,000 |
| Florence Anthony A. Jr. | 10% Owner | 07/22/2019 | 6,750,000 |
| Chang Carmen | 10% Owner | 07/22/2019 | 6,750,000 |
| Behbahani Ali | 10% Owner | 07/22/2019 | 6,750,000 |
| BASKETT FOREST | 10% Owner | 07/22/2019 | 6,750,000 |
| BARRIS PETER J | 10% Owner | 07/22/2019 | 6,750,000 |
| New Enterprise Associates 16, L.P. | 10% Owner | 07/22/2019 | 6,750,000 |
| Frazier Life Sciences IX, L.P. | 10% Owner | 07/22/2019 | 6,750,000 |
| O'Donnell Niall | Director | 07/22/2019 | 4,500,000 |
| Heron Patrick J | Director | 07/22/2019 | 6,750,000 |
| Flynn James E | 10% Owner | 07/22/2019 | 2,490,000 |
| Flynn James E | 10% Owner | 07/22/2019 | 2,490,000 |
| Novo Holdings A/S | 10% Owner | 07/22/2019 | 8,625,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN MIRUM PHARMACEUTICALS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,032,335 | 1.09% | Exited | Other |
| BLACKROCK INC. | 2,030,375 | 0.00145% | 18.75% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 525,562 | 0.0016% | 25.67% | Other |
| PALO ALTO INVESTORS LP | 64,700 | 0.14% | No change | Other |
| UBS OCONNOR LLC | 24,000 | 0.02% | New | Value |
| AQR CAPITAL MANAGEMENT LLC | 12,226 | 0.00067% | -15.95% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 11,600 | 0.00043% | -14.71% | Other |
| TUDOR INVESTMENT CORP ET AL | 11,937 | 0.00368% | New | Event Driven, Other |
| BALYASNY ASSET MANAGEMENT L.P. | 10,250 | 0.00062% | Exited | Event Driven |
CHANGE IN SHARES OUTSTANDING FOR MIRUM PHARMACEUTICALS INC
STOCK BUYBACKS FOR MIRUM PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 06/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2023
1.15%
1Q
12/31/2022
1.74%
2Q
09/30/2022
9.10%
3Q
06/30/2022
18.42%
4Q
03/31/2022
21.76%
5Q
12/31/2021
24.79%
6Q
09/30/2021
25.49%
7Q
06/30/2021
25.87%
8Q
03/31/2021
26.58%
9Q
12/31/2020
45.94%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR MIRUM PHARMACEUTICALS INC
LOADING...